These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 8105108)
1. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma. Kuhn EJ; Kurnot RA; Sesterhenn IA; Chang EH; Moul JW J Urol; 1993 Nov; 150(5 Pt 1):1427-33. PubMed ID: 8105108 [TBL] [Abstract][Full Text] [Related]
2. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines. Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965 [TBL] [Abstract][Full Text] [Related]
3. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease. Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689 [TBL] [Abstract][Full Text] [Related]
4. Expression of NEU/HER-2 oncoprotein (p185neu) in prostate tumors: an immunohistochemical study. Giri DK; Wadhwa SN; Upadhaya SN; Talwar GP Prostate; 1993; 23(4):329-36. PubMed ID: 7505056 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical detection of c-erbB-2 protein in human benign and neoplastic prostate. Ware JL; Maygarden SJ; Koontz WW; Strom SC Hum Pathol; 1991 Mar; 22(3):254-8. PubMed ID: 1672281 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of her-2/neu in human prostate cancer and benign hyperplasia. Gu K; Mes-Masson AM; Gauthier J; Saad F Cancer Lett; 1996 Feb; 99(2):185-9. PubMed ID: 8616823 [TBL] [Abstract][Full Text] [Related]
7. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients. Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202 [TBL] [Abstract][Full Text] [Related]
8. c-erbB-2 Oncoprotein expression is associated with poor prognosis in squamous cell carcinoma of the cervix. Oka K; Nakano T; Arai T Cancer; 1994 Feb; 73(3):664-71. PubMed ID: 7905364 [TBL] [Abstract][Full Text] [Related]
9. P-glycoprotein, HER-2/neu, and mutant p53 expression in human gynecologic tumors. Schneider J; Rubio MP; Barbazán MJ; Rodriguez-Escudero FJ; Seizinger BR; Castresana JS J Natl Cancer Inst; 1994 Jun; 86(11):850-5. PubMed ID: 7910219 [TBL] [Abstract][Full Text] [Related]
10. Expression of c-erbB-2 gene in human head and neck carcinoma. Craven JM; Pavelic ZP; Stambrook PJ; Pavelic L; Gapany M; Kelley DJ; Gapany S; Gluckman JL Anticancer Res; 1992; 12(6B):2273-6. PubMed ID: 1363518 [TBL] [Abstract][Full Text] [Related]
11. Expression of p160erbB-3 and p185erbB-2 in prostatic intraepithelial neoplasia and prostatic adenocarcinoma. Myers RB; Srivastava S; Oelschlager DK; Grizzle WE J Natl Cancer Inst; 1994 Aug; 86(15):1140-5. PubMed ID: 7913137 [TBL] [Abstract][Full Text] [Related]
12. [Expression of the cerbB-2 (HER-2/neu) oncoprotein in prostatic adenocarcinoma]. San Miguel Fraile P; Dos Santos JE; Pélaez Boismorand E; Ortiz Rey JA; Iglesias Rodríguez B; Cambronero Santos J; Fajardo Seijo JL; Rodríguez Costas JM; Fernández Regueiro M Actas Urol Esp; 2005 Jan; 29(1):64-9. PubMed ID: 15786765 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical demonstration of c-erbB-2 oncoprotein in gastric adenocarcinoma: comparison of cryostat and paraffin wax sections and effect of fixation. Chiu KY; Loke SL; Ho FC J Clin Pathol; 1994 Feb; 47(2):117-21. PubMed ID: 7907612 [TBL] [Abstract][Full Text] [Related]
14. p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. Mellon K; Thompson S; Charlton RG; Marsh C; Robinson M; Lane DP; Harris AL; Horne CH; Neal DE J Urol; 1992 Feb; 147(2):496-9. PubMed ID: 1370701 [TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of c-erbB-2 and estrogen receptor status in human breast cancer. McCann AH; Dervan PA; O'Regan M; Codd MB; Gullick WJ; Tobin BM; Carney DN Cancer Res; 1991 Jun; 51(12):3296-303. PubMed ID: 1674898 [TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of c-erbB-2 proto-oncogene product in prostatic cancer]. Kokuho M; Yoshiki T; Hamaguchi A; Okada Y; Tomoyoshi T; Higuchi K Nihon Hinyokika Gakkai Zasshi; 1993 Oct; 84(10):1872-8. PubMed ID: 7902885 [TBL] [Abstract][Full Text] [Related]
17. Correlation between c-erbB-2 amplification and risk of recurrent disease in node-negative breast cancer. Paterson MC; Dietrich KD; Danyluk J; Paterson AH; Lees AW; Jamil N; Hanson J; Jenkins H; Krause BE; McBlain WA Cancer Res; 1991 Jan; 51(2):556-67. PubMed ID: 1670762 [TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical study on the expression of c-erbB-2 oncoprotein in breast cancer. Horiguchi J; Iino Y; Takei H; Yokoe T; Ishida T; Morishita Y Oncology; 1994; 51(1):47-51. PubMed ID: 7903441 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Sugano S; Mukai K; Tsuda H; Hirohashi S; Furuya S; Shimosato Y; Ebihara S; Takeyama I Laryngoscope; 1992 Aug; 102(8):923-7. PubMed ID: 1353853 [TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of co-expression of c-erbB-2 oncoprotein and epidermal growth factor receptor in breast cancer patients. Osaki A; Toi M; Yamada H; Kawami H; Kuroi K; Toge T Am J Surg; 1992 Oct; 164(4):323-6. PubMed ID: 1357997 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]